These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34177192)

  • 1. COVID-19 Vaccines in Patients With Chronic Liver Disease.
    Sharma A; Patnaik I; Kumar A; Gupta R
    J Clin Exp Hepatol; 2021; 11(6):720-726. PubMed ID: 34177192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
    Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
    J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation.
    Alqahtani SA; Barry M; Memish Z; Hashim A; Alfares MA; Alghamdi SA; Al-Hamoudi WK; Al-Judaibi B; Alhazzani W; Al-Tawfiq JA; Abaalkhail F
    Saudi J Gastroenterol; 2021; 27(4):201-207. PubMed ID: 34100388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Liver Disease and Cirrhosis are Associated with Worse Outcomes Following SARS-CoV-2 Infection.
    Wong RJ; Zhang Y; Thamer M
    J Clin Exp Hepatol; 2023; 13(4):592-600. PubMed ID: 36777086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study.
    Satapathy SK; Roth NC; Kvasnovsky C; Hirsch JS; Trindade AJ; Molmenti E; Barish M; Hirschwerk D; Da BL; Bernstein D;
    Hepatol Int; 2021 Jun; 15(3):766-779. PubMed ID: 33826042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and the liver: What do we know so far?
    Nasa P; Alexander G
    World J Hepatol; 2021 May; 13(5):522-532. PubMed ID: 34131467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between COVID-19 and chronic liver disease: Mechanism, diagnosis, damage, and treatment.
    Qi RB; Wu ZH
    World J Virol; 2023 Jan; 12(1):22-29. PubMed ID: 36743657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccination and liver disease.
    Ozaka S; Kobayashi T; Mizukami K; Murakami K
    World J Gastroenterol; 2022 Dec; 28(48):6791-6810. PubMed ID: 36632314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update.
    Sripongpun P; Pinpathomrat N; Bruminhent J; Kaewdech A
    Front Med (Lausanne); 2022; 9():924454. PubMed ID: 35814781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Pegylated Interferon in Patients with Chronic Liver Diseases in the Context of SARS-CoV-2 Infection.
    Akbar SM; Mahtab MA; Aguilar JC; Uddin MH; Khan MSI; Yoshida O; Penton E; Gerardo GN; Hiasa Y
    Euroasian J Hepatogastroenterol; 2021; 11(1):27-31. PubMed ID: 34316461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus Disease-2019 and Implications on the Liver.
    Campbell PT; Fix OK
    Clin Liver Dis; 2023 Feb; 27(1):27-45. PubMed ID: 36400465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic.
    Kim D; Bonham CA; Konyn P; Cholankeril G; Ahmed A
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2664-2666.e2. PubMed ID: 34256143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation.
    Choudhary NS; Dhampalwar S; Saraf N; Soin AS
    J Clin Exp Hepatol; 2021; 11(6):713-719. PubMed ID: 33994708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver disease in the era of COVID-19: Is the worst yet to come?
    Mikolasevic I; Bozic D; Pavić T; Ruzic A; Hauser G; Radic M; Radic-Kristo D; Razov-Radas M; Puljiz Z; Milic S
    World J Gastroenterol; 2021 Sep; 27(36):6039-6052. PubMed ID: 34629818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: Coronavirus Vaccine Development Updates.
    Zhao J; Zhao S; Ou J; Zhang J; Lan W; Guan W; Wu X; Yan Y; Zhao W; Wu J; Chodosh J; Zhang Q
    Front Immunol; 2020; 11():602256. PubMed ID: 33424848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent challenges facing patients with preexisting chronic liver disease in the era of the COVID-19 pandemic.
    Mani I; Alexopoulou A
    Ann Gastroenterol; 2021; 34(5):625-633. PubMed ID: 34475732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines.
    Flanagan KL; Best E; Crawford NW; Giles M; Koirala A; Macartney K; Russell F; Teh BW; Wen SC
    Front Immunol; 2020; 11():579250. PubMed ID: 33123165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.